CDC LOCS Lab Advisory: Updated LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results

On Friday, July 24, CDC updated the LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Tests to include new data elements in the “LOINC Mapping” tab:

• Testkit Name ID
• Testkit Name ID Type
• LOINC Order Code
• LOINC Order Code Long Name
• LOINC Version ID

Additionally, the updated version includes a new “LOINC Mapping Columns” tab, which contains the column descriptions from the LIVD Spreadsheet Guidance document.

Required Data Elements:

CDC’s update aligns with the U.S. Department of Health and Human Services (HHS) guidance related to laboratory test result reporting as specified in the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The additional data elements provided in the LIVD mapping are required for the transmission of complete SARS-CoV-2  laboratory testing data to the CDC or the HHS Secretary’s designee.

Online resources:

• SARS-CoV-2 LOINC codes and Basics
• SNOMED CT Basics
• FDA FAQs on Diagnostic Testing for SARS-CoV-2
• FDA Emergency Use Authorizations
• NIH Value Set Authority for COVID-19
• Interoperability Standards Advisory for COVID-19 Pandemic
• Clinical Laboratory COVID-19 Response Weekly Calls
• CDC’s Laboratory Outreach Communication System (LOCS)
• COVID-19 Information for Laboratories
• CDC COVID-19 website
• CDC COVID-19 Testing by Laboratories: Q & A
• Reporting COVID-19 Laboratory Data

This Lab Advisory was originally published by the CDC Laboratory Outreach Communication System (LOCS) here.